Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Long-Term Investments (2019 - 2025)

Inspire Medical Systems' Long-Term Investments history spans 7 years, with the latest figure at $96.3 million for Q4 2025.

  • For Q4 2025, Long-Term Investments rose 35.69% year-over-year to $96.3 million; the TTM value through Dec 2025 reached $96.3 million, up 35.69%, while the annual FY2025 figure was $96.3 million, 35.69% up from the prior year.
  • Long-Term Investments for Q4 2025 was $96.3 million at Inspire Medical Systems, up from $88.4 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $113.4 million in Q3 2024 and bottomed at $204000.0 in Q1 2021.
  • The 5-year median for Long-Term Investments is $26.3 million (2024), against an average of $42.0 million.
  • The largest annual shift saw Long-Term Investments plummeted 46.46% in 2021 before it soared 4701.96% in 2022.
  • A 5-year view of Long-Term Investments shows it stood at $9.9 million in 2021, then dropped by 1.43% to $9.8 million in 2022, then dropped by 6.67% to $9.1 million in 2023, then soared by 676.5% to $71.0 million in 2024, then soared by 35.69% to $96.3 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Long-Term Investments are $96.3 million (Q4 2025), $88.4 million (Q3 2025), and $109.8 million (Q2 2025).